Raltitrexed (Tomudex™) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials
- 1 March 1999
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 35, S14-S18
- https://doi.org/10.1016/s0959-8049(99)00043-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Oxaliplatin: A review of preclinical and clinical studiesAnnals of Oncology, 1998
- Medical management of advanced gastric cancerCancer Treatment Reviews, 1998
- Mature results from three large controlled studies with raltitrexed ('Tomudex')British Journal of Cancer, 1998
- 1180: First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trialEuropean Journal Of Cancer, 1997
- Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancerEuropean Journal Of Cancer, 1997
- Chemotherapy of gastric cancerAnti-Cancer Drugs, 1996
- Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidinesAnnals of Oncology, 1996
- Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerBritish Journal of Cancer, 1995
- Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancerCancer, 1993
- Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental dataBiomedicine & Pharmacotherapy, 1989